Ariad shares up premarket after Iclusig trial results over the weekend
June 02, 2014 at 07:02 AM EDT
Shares of Ariad Pharmaceuticals were up this morning in premarket trading after results of two trials of its approved cancer drug, Iclusig, were announced over the weekend...